Related Experiment Video
Updated: May 7, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor
Published on: September 13, 2018
YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function
Ryouhei Tsutsumi1, Mohammad Masoudi, Atsushi Takahashi
1Department of Microbiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Abstract:
SHP2 is a ubiquitously expressed protein tyrosine phosphatase, deregulation of which is associated with malignant neoplasms and developmental disorders. SHP2 is required for full activation of RAS-Erk signaling in the cytoplasm and is also present in the nucleus, where it promotes Wnt target gene activation through dephosphorylation of parafibromin. SHP2 is distributed both to the cytoplasm and nucleus at low cell density but is excluded from the nucleus at high cell density. Here, we show that SHP2 physically interacts with transcriptional coactivators YAP and TAZ, targets of the cell-density-sensing Hippo signal. Through the interaction, nonphosphorylated YAP/TAZ promote nuclear translocalization of SHP2, which in turn stimulates TCF/LEF- and TEAD-regulated genes via parafibromin dephosphorylation. Conversely, YAP/TAZ phosphorylated by Hippo signaling sequester SHP2 in the cytoplasm, thereby preventing nuclear accumulation of SHP2. Hence, YAP/TAZ serve as a rheostat for nuclear SHP2 function, which is switched off by the Hippo signal.
Insights
The protein tyrosine phosphatase SHP2 interacts with YAP/TAZ, influencing their nuclear entry. Hippo signaling controls this interaction, regulating SHP2
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- SHP2 (a protein tyrosine phosphatase) plays a role in RAS-Erk signaling and Wnt target gene activation.
- SHP2 localization shifts between cytoplasm and nucleus based on cell density.
- Deregulation of SHP2 is linked to cancers and developmental disorders.
Purpose of the Study:
- To investigate the interaction between SHP2 and transcriptional coactivators YAP/TAZ.
- To elucidate the role of the Hippo signaling pathway in regulating SHP2 nuclear localization.
- To understand how cell density affects SHP2 function through YAP/TAZ.
Main Methods:
- Co-immunoprecipitation to detect physical interactions between SHP2, YAP, and TAZ.
- Western blotting to assess protein phosphorylation status.
- Confocal microscopy to visualize subcellular localization of SHP2, YAP, and TAZ.
Main Results:
- SHP2 physically interacts with YAP and TAZ.
- Non-phosphorylated YAP/TAZ promote nuclear translocation of SHP2, enhancing TCF/LEF- and TEAD-regulated gene expression via parafibromin dephosphorylation.
- Hippo-mediated phosphorylation of YAP/TAZ sequesters SHP2 in the cytoplasm, inhibiting its nuclear accumulation.
Conclusions:
- YAP/TAZ act as a rheostat controlling nuclear SHP2 activity.
- The Hippo signaling pathway regulates SHP2 function by modulating YAP/TAZ phosphorylation and subsequent SHP2 localization.
- This mechanism links cell density sensing to the regulation of gene transcription mediated by SHP2, YAP, and TAZ.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

